HEADER ANTIVIRAL PROTEIN/RNA 05-JAN-26 9ZY0 TITLE CRYO-EM STRUCTURE OF THE MONOMERIC HIV-2 VIF-HUMAN APOBEC3H-CBFBETA TITLE 2 COMPLEX COMPND MOL_ID: 1; COMPND 2 MOLECULE: VIRION INFECTIVITY FACTOR; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: CORE-BINDING FACTOR SUBUNIT BETA; COMPND 7 CHAIN: B; COMPND 8 SYNONYM: CBF-BETA,POLYOMAVIRUS ENHANCER-BINDING PROTEIN 2 BETA COMPND 9 SUBUNIT,PEA2-BETA,PEBP2-BETA,SL3-3 ENHANCER FACTOR 1 SUBUNIT BETA, COMPND 10 SL3/AKV CORE-BINDING FACTOR BETA SUBUNIT; COMPND 11 ENGINEERED: YES; COMPND 12 MOL_ID: 3; COMPND 13 MOLECULE: SINGLE-STRANDED DNA CYTOSINE DEAMINASE; COMPND 14 CHAIN: C; COMPND 15 EC: 3.5.4.38; COMPND 16 ENGINEERED: YES; COMPND 17 MOL_ID: 4; COMPND 18 MOLECULE: RNA (5'-R(P*UP*UP*UP*UP*UP*UP*UP*U)-3'); COMPND 19 CHAIN: D; COMPND 20 ENGINEERED: YES; COMPND 21 MOL_ID: 5; COMPND 22 MOLECULE: RNA (5'-R(P*AP*AP*AP*AP*AP*AP*AP*A)-3'); COMPND 23 CHAIN: E; COMPND 24 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HUMAN IMMUNODEFICIENCY VIRUS 2; SOURCE 3 ORGANISM_TAXID: 11709; SOURCE 4 GENE: VIF; SOURCE 5 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 6 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 10 ORGANISM_COMMON: HUMAN; SOURCE 11 ORGANISM_TAXID: 9606; SOURCE 12 GENE: CBFB; SOURCE 13 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 14 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 15 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 16 MOL_ID: 3; SOURCE 17 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 18 ORGANISM_COMMON: HUMAN; SOURCE 19 ORGANISM_TAXID: 9606; SOURCE 20 GENE: APOBEC3H; SOURCE 21 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 22 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 23 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 24 MOL_ID: 4; SOURCE 25 ORGANISM_SCIENTIFIC: SYNTHETIC CONSTRUCT; SOURCE 26 ORGANISM_TAXID: 32630; SOURCE 27 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 28 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 29 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 30 MOL_ID: 5; SOURCE 31 ORGANISM_SCIENTIFIC: SYNTHETIC CONSTRUCT; SOURCE 32 ORGANISM_TAXID: 32630; SOURCE 33 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 34 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 35 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS HIV-2, VIF, APOBEC3H, ANTAGONISM, UBIQUITINATION, ANTIVIRAL PROTEIN, KEYWDS 2 ANTIVIRAL PROTEIN-RNA COMPLEX EXPDTA ELECTRON MICROSCOPY AUTHOR Y.NIU,M.LILLY,E.K.RONAYNE,M.EMERMAN,N.M.CHESARINO,J.D.GROSS REVDAT 1 15-JUL-26 9ZY0 0 JRNL AUTH Y.NIU,M.LILLY,E.K.RONAYNE,M.EMERMAN,N.M.CHESARINO,J.D.GROSS JRNL TITL THE STRUCTURAL MECHANISM OF HIV-2 VIF ANTAGONISM OF HUMAN JRNL TITL 2 APOBEC3H. JRNL REF NAT COMMUN 2026 JRNL REFN ESSN 2041-1723 JRNL PMID 42373647 JRNL DOI 10.1038/S41467-026-75045-1 REMARK 2 REMARK 2 RESOLUTION. 3.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 SOFTWARE PACKAGES : CRYOSPARC, CRYOSPARC REMARK 3 RECONSTRUCTION SCHEMA : NULL REMARK 3 REMARK 3 EM MAP-MODEL FITTING AND REFINEMENT REMARK 3 PDB ENTRY : NULL REMARK 3 REFINEMENT SPACE : NULL REMARK 3 REFINEMENT PROTOCOL : NULL REMARK 3 REFINEMENT TARGET : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE : NULL REMARK 3 REMARK 3 FITTING PROCEDURE : NULL REMARK 3 REMARK 3 EM IMAGE RECONSTRUCTION STATISTICS REMARK 3 NOMINAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 ACTUAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 EFFECTIVE RESOLUTION (ANGSTROMS) : 3.200 REMARK 3 NUMBER OF PARTICLES : 545960 REMARK 3 CTF CORRECTION METHOD : PHASE FLIPPING AND AMPLITUDE REMARK 3 CORRECTION REMARK 3 REMARK 3 EM RECONSTRUCTION MAGNIFICATION CALIBRATION: NULL REMARK 3 REMARK 3 OTHER DETAILS: NULL REMARK 4 REMARK 4 9ZY0 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 09-JAN-26. REMARK 100 THE DEPOSITION ID IS D_1000303406. REMARK 245 REMARK 245 EXPERIMENTAL DETAILS REMARK 245 RECONSTRUCTION METHOD : SINGLE PARTICLE REMARK 245 SPECIMEN TYPE : NULL REMARK 245 REMARK 245 ELECTRON MICROSCOPE SAMPLE REMARK 245 SAMPLE TYPE : PARTICLE REMARK 245 PARTICLE TYPE : POINT REMARK 245 NAME OF SAMPLE : HIV-2 VIF IN COMPLEX WITH HUMAN REMARK 245 APOBEC3H AND CBFBETA REMARK 245 SAMPLE CONCENTRATION (MG ML-1) : NULL REMARK 245 SAMPLE SUPPORT DETAILS : NULL REMARK 245 SAMPLE VITRIFICATION DETAILS : NULL REMARK 245 SAMPLE BUFFER : NULL REMARK 245 PH : 7.20 REMARK 245 SAMPLE DETAILS : NULL REMARK 245 REMARK 245 DATA ACQUISITION REMARK 245 DATE OF EXPERIMENT : NULL REMARK 245 NUMBER OF MICROGRAPHS-IMAGES : NULL REMARK 245 TEMPERATURE (KELVIN) : NULL REMARK 245 MICROSCOPE MODEL : TFS KRIOS REMARK 245 DETECTOR TYPE : GATAN K3 (6K X 4K) REMARK 245 MINIMUM DEFOCUS (NM) : 1200.00 REMARK 245 MAXIMUM DEFOCUS (NM) : 2500.00 REMARK 245 MINIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 MAXIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 NOMINAL CS : NULL REMARK 245 IMAGING MODE : BRIGHT FIELD REMARK 245 ELECTRON DOSE (ELECTRONS NM**-2) : 4770.00 REMARK 245 ILLUMINATION MODE : OTHER REMARK 245 NOMINAL MAGNIFICATION : NULL REMARK 245 CALIBRATED MAGNIFICATION : NULL REMARK 245 SOURCE : FIELD EMISSION GUN REMARK 245 ACCELERATION VOLTAGE (KV) : 300 REMARK 245 IMAGING DETAILS : NULL REMARK 247 REMARK 247 ELECTRON MICROSCOPY REMARK 247 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM ELECTRON REMARK 247 MICROSCOPY DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE REMARK 247 THAT CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES REMARK 247 ON THESE RECORDS ARE MEANINGLESS EXCEPT FOR THE CALCULATION REMARK 247 OF THE STRUCTURE FACTORS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: PENTAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D, E REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 PRO A 162 REMARK 465 GLN A 163 REMARK 465 ARG A 164 REMARK 465 ASN A 165 REMARK 465 SER A 166 REMARK 465 THR A 167 REMARK 465 THR A 168 REMARK 465 ARG A 169 REMARK 465 LYS A 170 REMARK 465 GLN A 171 REMARK 465 TRP A 172 REMARK 465 ARG A 173 REMARK 465 ARG A 174 REMARK 465 ASP A 175 REMARK 465 TYR A 176 REMARK 465 ARG A 177 REMARK 465 ARG A 178 REMARK 465 GLY A 179 REMARK 465 LEU A 180 REMARK 465 ARG A 181 REMARK 465 VAL A 182 REMARK 465 ALA A 183 REMARK 465 ARG A 184 REMARK 465 GLN A 185 REMARK 465 ASP A 186 REMARK 465 SER A 187 REMARK 465 ARG A 188 REMARK 465 GLY A 189 REMARK 465 LEU A 190 REMARK 465 LYS A 191 REMARK 465 GLN A 192 REMARK 465 ARG A 193 REMARK 465 GLY A 194 REMARK 465 GLY A 195 REMARK 465 GLU A 196 REMARK 465 SER A 197 REMARK 465 PRO A 198 REMARK 465 ALA A 199 REMARK 465 PRO A 200 REMARK 465 MET B 1 REMARK 465 PRO B 2 REMARK 465 ARG B 3 REMARK 465 VAL B 4 REMARK 465 ASP B 155 REMARK 465 ARG B 156 REMARK 465 ASP B 157 REMARK 465 ARG B 158 REMARK 465 SER B 159 REMARK 465 HIS B 160 REMARK 465 ARG B 161 REMARK 465 GLU B 162 REMARK 465 GLU B 163 REMARK 465 MET B 164 REMARK 465 GLU B 165 REMARK 465 VAL B 166 REMARK 465 ARG B 167 REMARK 465 VAL B 168 REMARK 465 SER B 169 REMARK 465 GLN B 170 REMARK 465 LEU B 171 REMARK 465 LEU B 172 REMARK 465 ALA B 173 REMARK 465 VAL B 174 REMARK 465 THR B 175 REMARK 465 GLY B 176 REMARK 465 LYS B 177 REMARK 465 LYS B 178 REMARK 465 THR B 179 REMARK 465 THR B 180 REMARK 465 ARG B 181 REMARK 465 PRO B 182 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 U D 1 P U D 1 OP3 -0.128 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 18 -165.59 -79.69 REMARK 500 ALA A 50 115.72 -160.63 REMARK 500 PHE A 114 145.02 69.24 REMARK 500 TYR A 137 65.69 -156.52 REMARK 500 GLU A 212 25.61 48.35 REMARK 500 ARG B 149 33.61 -96.33 REMARK 500 SER C 129 33.83 -95.70 REMARK 500 PHE C 148 22.00 -142.44 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A 301 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS A 110 NE2 REMARK 620 2 CYS A 116 SG 129.0 REMARK 620 3 CYS A 135 SG 120.3 110.1 REMARK 620 N 1 2 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: EMD-74939 RELATED DB: EMDB REMARK 900 CRYO-EM STRUCTURE OF THE MONOMERIC HIV-2 VIF-HUMAN APOBEC3H-CBFBETA REMARK 900 COMPLEX DBREF 9ZY0 A 1 215 UNP Q9YTT9 Q9YTT9_9HIV2 1 215 DBREF 9ZY0 B 1 182 UNP Q13951 PEBB_HUMAN 1 182 DBREF 9ZY0 C 1 183 UNP B7TQM6 B7TQM6_HUMAN 1 183 DBREF 9ZY0 D 1 8 PDB 9ZY0 9ZY0 1 8 DBREF 9ZY0 E 7 14 PDB 9ZY0 9ZY0 7 14 SEQRES 1 A 215 MET GLU GLU GLY LYS SER TRP ILE VAL VAL PRO THR TRP SEQRES 2 A 215 ARG VAL PRO GLY ARG MET GLU LYS TRP HIS SER LEU VAL SEQRES 3 A 215 LYS TYR LEU LYS TYR ARG THR LYS ASP LEU GLU LYS VAL SEQRES 4 A 215 CYS TYR VAL PRO HIS HIS LYS VAL GLY TRP ALA TRP TRP SEQRES 5 A 215 THR CYS SER ARG VAL ILE PHE PRO LEU GLN GLY ARG SER SEQRES 6 A 215 HIS LEU GLU ILE GLN ALA TYR TRP ASN LEU THR PRO GLU SEQRES 7 A 215 LYS GLY TRP LEU SER SER TYR ALA VAL ARG ILE THR TRP SEQRES 8 A 215 TYR THR GLU LYS PHE TRP THR ASP VAL THR PRO ASP CYS SEQRES 9 A 215 ALA ASP SER LEU ILE HIS GLY THR TYR PHE SER CYS PHE SEQRES 10 A 215 THR ALA GLY GLU VAL ARG ARG ALA ILE ARG GLY GLU LYS SEQRES 11 A 215 LEU LEU SER CYS CYS ASN TYR PRO GLN ALA HIS LYS SER SEQRES 12 A 215 GLN VAL PRO SER LEU GLN PHE LEU ALA LEU VAL VAL VAL SEQRES 13 A 215 GLN GLN ASN GLY LYS PRO GLN ARG ASN SER THR THR ARG SEQRES 14 A 215 LYS GLN TRP ARG ARG ASP TYR ARG ARG GLY LEU ARG VAL SEQRES 15 A 215 ALA ARG GLN ASP SER ARG GLY LEU LYS GLN ARG GLY GLY SEQRES 16 A 215 GLU SER PRO ALA PRO GLY ALA HIS PHE PRO GLY VAL ALA SEQRES 17 A 215 LYS VAL LEU GLU ILE LEU ALA SEQRES 1 B 182 MET PRO ARG VAL VAL PRO ASP GLN ARG SER LYS PHE GLU SEQRES 2 B 182 ASN GLU GLU PHE PHE ARG LYS LEU SER ARG GLU CYS GLU SEQRES 3 B 182 ILE LYS TYR THR GLY PHE ARG ASP ARG PRO HIS GLU GLU SEQRES 4 B 182 ARG GLN ALA ARG PHE GLN ASN ALA CYS ARG ASP GLY ARG SEQRES 5 B 182 SER GLU ILE ALA PHE VAL ALA THR GLY THR ASN LEU SER SEQRES 6 B 182 LEU GLN PHE PHE PRO ALA SER TRP GLN GLY GLU GLN ARG SEQRES 7 B 182 GLN THR PRO SER ARG GLU TYR VAL ASP LEU GLU ARG GLU SEQRES 8 B 182 ALA GLY LYS VAL TYR LEU LYS ALA PRO MET ILE LEU ASN SEQRES 9 B 182 GLY VAL CYS VAL ILE TRP LYS GLY TRP ILE ASP LEU GLN SEQRES 10 B 182 ARG LEU ASP GLY MET GLY CYS LEU GLU PHE ASP GLU GLU SEQRES 11 B 182 ARG ALA GLN GLN GLU ASP ALA LEU ALA GLN GLN ALA PHE SEQRES 12 B 182 GLU GLU ALA ARG ARG ARG THR ARG GLU PHE GLU ASP ARG SEQRES 13 B 182 ASP ARG SER HIS ARG GLU GLU MET GLU VAL ARG VAL SER SEQRES 14 B 182 GLN LEU LEU ALA VAL THR GLY LYS LYS THR THR ARG PRO SEQRES 1 C 183 MET ALA LEU LEU THR ALA GLU THR PHE ARG LEU GLN PHE SEQRES 2 C 183 ASN ASN LYS ARG ARG LEU ARG ARG PRO TYR TYR PRO ARG SEQRES 3 C 183 LYS ALA LEU LEU CYS TYR GLN LEU THR PRO GLN ASN GLY SEQRES 4 C 183 SER THR PRO THR ARG GLY TYR PHE GLU ASN LYS LYS LYS SEQRES 5 C 183 CYS HIS ALA GLU ILE CYS PHE ILE ASN GLU ILE LYS SER SEQRES 6 C 183 MET GLY LEU ASP GLU THR GLN CYS TYR GLN VAL THR CYS SEQRES 7 C 183 TYR LEU THR TRP SER PRO CYS SER SER CYS ALA TRP GLU SEQRES 8 C 183 LEU VAL ASP PHE ILE LYS ALA HIS ASP HIS LEU ASN LEU SEQRES 9 C 183 ARG ILE PHE ALA SER ARG LEU TYR TYR HIS TRP CYS LYS SEQRES 10 C 183 PRO GLN GLN ASP GLY LEU ARG LEU LEU CYS GLY SER GLN SEQRES 11 C 183 VAL PRO VAL GLU VAL MET GLY PHE PRO GLU PHE ALA ASP SEQRES 12 C 183 CYS TRP GLU ASN PHE VAL ASP HIS GLU LYS PRO LEU SER SEQRES 13 C 183 PHE ASN PRO TYR LYS MET LEU GLU GLU LEU ASP LYS ASN SEQRES 14 C 183 SER ARG ALA ILE LYS ARG ARG LEU ASP ARG ILE LYS GLN SEQRES 15 C 183 SER SEQRES 1 D 8 U U U U U U U U SEQRES 1 E 8 A A A A A A A A HET ZN A 301 1 HET ZN C 201 1 HETNAM ZN ZINC ION FORMUL 6 ZN 2(ZN 2+) HELIX 1 AA1 MET A 19 ARG A 32 1 14 HELIX 2 AA2 PRO A 43 VAL A 47 5 5 HELIX 3 AA3 THR A 101 HIS A 110 1 10 HELIX 4 AA4 THR A 118 GLY A 128 1 11 HELIX 5 AA5 TYR A 137 LYS A 142 5 6 HELIX 6 AA6 SER A 147 GLY A 160 1 14 HELIX 7 AA7 GLY A 206 LEU A 211 1 6 HELIX 8 AA8 PRO B 6 GLU B 15 1 10 HELIX 9 AA9 GLU B 15 ARG B 23 1 9 HELIX 10 AB1 PRO B 36 ASP B 50 1 15 HELIX 11 AB2 SER B 82 GLU B 84 5 3 HELIX 12 AB3 ASP B 128 GLU B 135 1 8 HELIX 13 AB4 ASP B 136 ARG B 149 1 14 HELIX 14 AB5 THR C 5 PHE C 13 1 9 HELIX 15 AB6 HIS C 54 GLY C 67 1 14 HELIX 16 AB7 CYS C 85 HIS C 99 1 15 HELIX 17 AB8 CYS C 116 SER C 129 1 14 HELIX 18 AB9 GLY C 137 PHE C 148 1 12 HELIX 19 AC1 ASN C 158 SER C 183 1 26 SHEET 1 AA112 CYS A 40 VAL A 42 0 SHEET 2 AA112 ARG A 56 LEU A 61 -1 O ILE A 58 N CYS A 40 SHEET 3 AA112 SER A 65 TYR A 72 -1 O LEU A 67 N PHE A 59 SHEET 4 AA112 TYR A 85 TYR A 92 -1 O THR A 90 N GLU A 68 SHEET 5 AA112 TRP A 7 VAL A 15 -1 N VAL A 15 O TYR A 85 SHEET 6 AA112 LEU B 64 PRO B 70 -1 O PHE B 69 N ILE A 8 SHEET 7 AA112 ILE B 55 ALA B 59 -1 N ILE B 55 O PHE B 68 SHEET 8 AA112 CYS B 25 LYS B 28 -1 N LYS B 28 O VAL B 58 SHEET 9 AA112 ASP B 120 PHE B 127 -1 O GLY B 123 N CYS B 25 SHEET 10 AA112 VAL B 106 ASP B 115 -1 N LYS B 111 O CYS B 124 SHEET 11 AA112 LYS B 94 LEU B 103 -1 N ALA B 99 O TRP B 110 SHEET 12 AA112 VAL B 86 ASP B 87 -1 N ASP B 87 O TYR B 96 SHEET 1 AA2 7 CYS A 40 VAL A 42 0 SHEET 2 AA2 7 ARG A 56 LEU A 61 -1 O ILE A 58 N CYS A 40 SHEET 3 AA2 7 SER A 65 TYR A 72 -1 O LEU A 67 N PHE A 59 SHEET 4 AA2 7 TYR A 85 TYR A 92 -1 O THR A 90 N GLU A 68 SHEET 5 AA2 7 TRP A 97 ASP A 99 -1 O THR A 98 N TRP A 91 SHEET 6 AA2 7 LYS B 94 LEU B 103 1 O ILE B 102 N ASP A 99 SHEET 7 AA2 7 VAL B 86 ASP B 87 -1 N ASP B 87 O TYR B 96 SHEET 1 AA3 4 THR C 43 PHE C 47 0 SHEET 2 AA3 4 LEU C 30 PRO C 36 -1 N LEU C 34 O THR C 43 SHEET 3 AA3 4 TYR C 74 TRP C 82 -1 O THR C 77 N GLN C 33 SHEET 4 AA3 4 LEU C 102 ARG C 110 1 O ASN C 103 N VAL C 76 LINK NE2 HIS A 110 ZN ZN A 301 1555 1555 2.31 LINK SG CYS A 116 ZN ZN A 301 1555 1555 2.31 LINK SG CYS A 135 ZN ZN A 301 1555 1555 2.31 CISPEP 1 ARG C 21 PRO C 22 0 0.98 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 CONECT 940 4561 CONECT 986 4561 CONECT 1131 4561 CONECT 4561 940 986 1131 MASTER 233 0 2 19 23 0 0 6 4557 5 4 48 END